How to use the speech recognition tool?
PIGMENT – PDE6A gene therapy for retinitis pigmentosa
PIGMENT – PDE6A gene therapy for retinitis pigmentosa.
Status of the trial: Active, Recruiting
Orphan Drug Recognition: Yes
- Opening Date: 2019-07-02
- Closing Date: 0000-00-00
Funder Type: national institution
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
- Retinal Rare Eye Diseases (WG1)
This ERN is supported by: